Several landmark cardiovascular outcome trials have demonstrated that GLP-1RAs can significantly reduce the risk of major adverse cardiovascular events (MACE), which include cardiovascular death, nonfatal myocardial infarction (heart attack), and nonfatal stroke [43]
Moreover, the way GSH depletion can lead to immune system failure and make the end organs in danger of oxidative stress-mediated damage needs to be explained
Continue reading for my own predictions and opinions regarding GLP-1s, and I invite your feedback
Oxidative stress: Relationship between generation of reactive species and defense of the organism
Because it affects how your body processes nutrients and medications, some drug combinations require careful monitoring or dose adjustments
Yet, GLP-1 drugs arent a cure-all to begin with, and even clinical trials found that patients lost weight while taking these medications in conjunction with making lifestyle habit changes